CHARLOTTESVILLE, VA, United States of America

Jenny Diaz-castaneda

This inventor holds 1 USPTO granted patent. Top assignee: University of Virginia Patent Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jenny Diaz-castaneda. Retrieved from https://idiyas.com/inventor/jenny-diaz-castaneda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jenny Diaz-Castaneda and Closed-Loop Glycemic Control

Introduction

Jenny Diaz-Castaneda is an inventor associated with the University of Virginia Patent Foundation. Her patent work addresses automated insulin delivery and the management of glucose fluctuations.

Latest Patents

Diaz-Castaneda is named on 1 patent: “Method and System of Closed Loop Control Improving Glycemic Response Following an Unannounced Source of Glycemic Fluctuation.” The invention describes a dual-mode closed-loop control system that combines personalized model predictive control, an automatic bolus priming system, and hyperglycemia mitigation. Together, these components are designed to adjust insulin delivery in response to glucose measurements and detected metabolic conditions, including an unannounced meal.

Career Highlights

Her listed patent reflects work on adaptive control methods for insulin infusion. The system uses recent control actions, glucose measurements, and their rates of change to personalize control strength and respond to glycemic fluctuations.

Collaborations

The patent lists Marc D. Breton and Jose Garcia-Tirado among Diaz-Castaneda’s coworkers. The invention is associated with the University of Virginia Patent Foundation.

Conclusion

Jenny Diaz-Castaneda’s patent contribution focuses on integrating adaptive insulin control, automatic bolus delivery, and hyperglycemia mitigation to improve responses to unexpected glucose fluctuations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…